Luye Pharma Group (HK:2186) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Luye Pharma Group Ltd. has successfully completed the initial phase of a significant investment deal with a third party in Shenzhen Luye, resulting in the Group retaining a 75% ownership and the Investor holding 25%. This strategic move, which includes an investor-nominated director joining Nanjing Luye’s board, signals the Group’s advancement to the next stage of investment, with future updates to be announced in due course.
For further insights into HK:2186 stock, check out TipRanks’ Stock Analysis page.
